Comprehensive metabolic modulations of sphingolipids are promising severity indicators in COVID‐19 - Uranbileg, Baasanjav; Isago, Hideaki; Nakayama, Hitoshi; Jubishi, Daisuke; Okamoto, Koh; Sakai, Eri; Kubota, Masayuki; Tsutsumi, Takeya; Moriya, Kyoji; Kurano, Makoto (The FASEB journal, 2024)
Keywords: Adult; Aged; Biomarkers - blood; Biomarkers - metabolism; COVID-19 - blood; COVID-19 - metabolism; COVID-19 - virology; COVID‐19; Female; hexosylceramide (HexCer); Humans; lactosylceramide (LacCer); Male; Middle Aged; SARS-CoV-2; Severity of Illness Index; sphingolipid; Sphingolipids - blood; Sphingolipids - metabolism; sphingosine (Sph); Sphingosine - analogs & derivatives; Sphingosine - metabolism; COVID‐19; hexosylceramide (HexCer); sphingolipid; lactosylceramide (LacCer); sphingosine (Sph)